索引于
  • 打开 J 门
  • Genamics 期刊搜索
  • 学术钥匙
  • 期刊目录
  • 全球影响因子 (GIF)
  • 中国知网(CNKI)
  • 乌尔里希的期刊目录
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-WorldCat
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • 欧洲酒吧
  • 谷歌学术
分享此页面
期刊传单
Flyer image

抽象的

Contemplations on the Use of Enzymes in the Downstream Processing of Pharmaceuticals

Sunpraze Evan

Compound helped measure steps can be found periodically in the downstream handling of exceptionally important biopharmaceuticals. The execution of such a stage will normally include the expansion of a specific measure of a cleaned compound arrangement to a product containing stream at a specific phase of the cycle. The progression is intended to exploit the synergist action of a protein in vitro to (i) encourage cell disturbance or cell separation, (ii) advance the debasement of cell derived impurities or (iii) perform unmistakable changes in the structure of key biomolecules. The enzymatic lysis and interruption of microbial cells as an early advance of item confinement is entrenched and goes back to the early long periods of present day Biotechnology.

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证